Article
Nashville, Tenn. - For the first time, molecular margin analysis has been performed in a timeframe suitable for intra-operative use during major head and neck squamous cell carcinoma resections, according to David Goldenberg, M.D.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.